65 results
PRE 14C
xg1te3u9p5 2k5riwx03
16 Dec 22
Preliminary information
4:31pm
8-K
EX-10.2
kdufe6x12smzvsy5
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
s01 udurx110abythech
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
tlt9bk 0e
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
D
2ur0q7cp4bk6c21zz
31 Aug 22
$5M in debt
2:58pm
8-K
EX-10.1
b19um
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm